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Following the outbreak of haemolytic uraemic syn-
drome (HUS) on June 2011 in south-western France, 
household transmission due to Escherichia coli 
O104:H4 was suspected for two cases who developed 
symptoms 9 and 10 days after onset of symptoms of 
the index case. The analysis of exposures and of the 
incubation period is in favour of a secondary transmis-
sion within the family. Recommendations should be 
reinforced to prevent person-to-person transmission 
within households.
Introduction
On 30 June 2011, an outbreak of haemolytic uraemic syn-
drome (HUS) and bloody diarrhoea was reported among 
attendees of an open day event at a children’s com-
munity centre that took place on 8 June in a town near 
Bordeaux, south-western France [1]. The identified strain 
was Shiga toxin 2-producing Escherichia coli O104:H4, 
with the same characteristics as the strain that caused 
the recent outbreak in Germany [2,3,4]. As of 26 July 
2011, 15 cases of bloody diarrhoea have been observed 
in relation with this event, nine of whom have devel-
oped HUS. An investigation was conducted to identify 
the vehicles of infection and to guide control measures. 
Preliminary results of interviews and trawling question-
naires suggested sprouts as the vehicle of transmission. 
Here we describe the two cases of HUS for whom house-
hold transmission of E. coli O104:H4 was suspected. The 
possibility of person-to-person transmission of E. coli 
O104:H4 has also been reported in the Netherlands [5].
Case descriptions
Patient A 
On 18 June, a man in his 40s was admitted in a hospi-
tal near Bordeaux, with abdominal pain and bloody 
diarrhoea of two days. Stool samples were sent to the 
National Reference Centre for E. coli and Shigella in 
Paris. Four days after admission, the patient left the 
hospital and returned home. On 27 June, he was hospi-
talised again in the nephrology department of Bordeaux 
University Hospital with a diagnosis of HUS. Test results 
from stool samples showed the presence of E. coli 
O104:H4 possessing the stx2 gene, encoding Shiga toxin 
2. The strain was negative for the gene coding for intimin 
(eae) but positive for aggR which regulates the expres-
sion of aggregative adherence fimbriae. The antimicro-
bial resistance pattern of the strain was similar to than 
seen in the outbreak strain in recent E. coli O104:H4 out-
break in Germany: ampicillin-resistant (R), cefotaxime-R, 
ceftazidime-R, imipenem-sensitive (S), streptomycin-R, 
kanamycin-S, gentamicin-S, sulfamethoxazole-R, tri-
methoprim-R, cotrimoxazole-R, tetracycline-R, chloram-
phenicol-S, nalidixic acid-R, and ciprofloxacin-R. The 
PCR analysis indicated the presence of the blaCTX-M-15 
gene, encoding an extended-spectrum beta-lactamase 
(ESBL), and the presence of the blaTEM gene, encoding 
a penicillinase. After treatment, the patient gradually 
recovered from HUS. He returned home on 6 July having 
received specific hygiene guidelines from the hospital, 
notably recommendations about hand-washing.
Patient A had participated in the open day event on 8 
June, accompanied by his three-year-old child (Patient 
B). His wife and his second five-year-old child did not 
attend. Patient A’s interview revealed that he had con-
sumed three kinds of sprouts (fenugreek, mustard, and 
rocket) during the event.
Patient B
The three-year-old child of Patient A presented first 
symptoms of illness on 26 June, i.e. 18 days after the 
2 www.eurosurveillance.org
open day and nine days after the onset of symptoms 
in Patient A. At onset, the child had abdominal pain 
followed after three days by bloody diarrhoea. Shiga 
toxin 2-producing E. coli O104:H4 was isolated from 
stool samples. Some bacterial colonies produced the 
ESBL, whereas others only the penicillinase. However, 
both types of colonies were also resistant to strepto-
mycin, sulfamethoxazole, trimethoprim, cotrimoxa-
zole, tetracycline, and nalidixic acid, as observed for 
other outbreak isolates [1]. On 3 July, the child devel-
oped anaemia, haemolysis and high urine protein-to-
creatinine ratio, compatible with HUS and was admitted 
to the paediatric department of Bordeaux University 
Hospital. On 4 July, thrombocytopenia developed. The 
child gradually recovered after treatment and was dis-
charged from hospital on 8 July.
Patient B had participated in the open day event but, 
according to Patient A, did not consume sprouts. As the 
children had no access to the buffet unless accompa-
nied by an adult, it is unlikely that the child has eaten 
any sprouts without the father’s knowledge.
Patient C
On 2 July, a woman in her 30s, wife of Patient A and 
mother of Patient B, was admitted to Bordeaux 
University Hospital with bloody diarrhoea of six days, 
i.e. she had had the first signs of disease on 27 June, 
respectively 10 and 1 days after the onset of illness 
in Patient A and Patient B. Shiga toxin 2-producing 
E. coli O104:H4 was isolated from her stool samples. 
It was resistant to ampicillin, streptomycin, sulfam-
ethoxazole, trimethoprim, cotrimoxazole, tetracycline, 
and nalidixic acid, but susceptible to extended-spec-
trum cephalosporins (i.e. only production of the 
penicillinase). The absence of the CTX-M-15 ESBL 
compared to the isolates from Patient A and some iso-
lates from Patient B might be due to the mobilisation 
of insertion sequences usually present in the vicinity 
of the blaCTX-M-15 gene. This might be in relation to the 
absence of selective pressure by this class of antimi-
crobials. Patient C developed symptoms of anaemia, 
haemolysis, thrombocytopenia and proteinuria on 8 
July. After treatment, she recovered gradually and she 
left the hospital on 12 July.
Patient C had not attended the open day event and not 
consumed any type of sprouts during the two months 
previously.
Family members
The five-year-old child spent the whole period at home. 
It did not develop any symptoms but was admitted to 
the paediatric department of Bordeaux University 
Hospital for observation from 3 to 4 July.
Two other relatives of Patients A, B and C shared meals 
in the family’s house on 26 June. One of them stayed 
in the family’s house between 29 June and 3 July and 
complained of severe fatigue. The other relative devel-
oped mild diarrhoea on 28 June. A rectal swab was per-
formed for both with an O104 serology for the relative 
with severe fatigue. Both relatives’ stool samples were 
negative for the presence of E. coli O104:H4.
Hypothesis of transmission
We hypothesised that Patients B and C both prob-
ably acquired HUS by secondary transmission from 
Patient A because they developed illness 9 and 10 
days, respectively, after Patient A’s symptom onset. 
Figure 
Two cases of probable household transmission of haemolytic uraemic syndrome due to Escherichia coli O104:H4, south-





















June 2011 July 2011
 Patient A (index case) Patient B Patient C
Time period between open day and DSO of Patients A and B (who attented the open day).
Time period between DSO of Patient A (index case) and Patients B and C
DSO: date of symptom onset; H: hospitalised (the day of discharge was not counted as day of hospitalisation).
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Although Patient B attended the open day event, 
food-borne transmission from the sprouts to patient 
B is unlikely because she reportedly did not eat any 
sprouts. Moreover, an incubation period of 18 days 
would be unusually long. Both Patients B and C had 
spent time with Patient A on the day when he first 
experienced symptoms and after his return from hos-
pital. During his first hospitalisation, his family did not 
stay in Bordeaux and had no contact with him.
A recent study by the German outbreak investigation 
team showed that the median incubation period of E. 
coli O104:H4 in that outbreak was eight days (interquar-
tile range: 7–9 days) [3]. Therefore, two scenarios can 
be considered for the household described here: trans-
mission on 17 June when Patient A first presented symp-
toms at home, or transmission between 22 and 26 June 
after his return from hospital. Between 22 and 26 June, 
patient A had symptoms of diarrhoea and severe fatigue; 
during this period, he had prepared some meals.
Recommendations for hygiene 
and infection control
Following the detection of the outbreak on 22 June 
2011, recommendations for hygiene and infection 
control were disseminated, starting on 24 June, to 
the general population and to the participants of the 
open day through several press releases, the web-
site of the Ministry of Health, and local physicians. 
Furthermore, following the probable household trans-
mission described here, a letter was sent on 5 July to 
the participants of the open day. This letter stressed 
the importance of personal hygiene measures, and 
safe food preparation practices, to reduce the risk of 
transmission. No other secondary cases in connection 
with the community event have been reported to date.
Here, as in the household transmission of E. coli 
O104:H4 reported in the Netherlands [5], the index case 
was an adult. In our episode, one of the two secondary 
cases was also an adult. A review of 90 confirmed out-
breaks caused by classical E. coli O157, showed that a 
lower median age of the index case was associated with 
a higher rate of secondary cases and that young children 
were most likely to become infected [6]. The unusual 
transmission from adult to adult observed in our epi-
sode is in line with the preponderance of cases in adults 
reported in the German outbreak [3]. This unusual pat-
tern could be attributable to the specific properties of 
this strain [4,7]. Measures to prevent secondary trans-
mission among adults should be strictly implemented.
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